AI tool can rapidly decode brain tumor DNA during surgery

FHS
July 7, 2023
11:28 pm

Scientists have designed an AI tool that can rapidly decode a brain tumor’s DNA to determine its molecular identity during surgery -; critical information that under the current approach can take a few days and up to a few weeks.

Cellectar to seek approval for radioactive iodine-based therapy in rare blood cancer

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 24, 2024

Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

The Colombian government has taken a significant step toward issuing a compulsory license for a widely used HIV treatment, the latest instance in which cash-strapped

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

AI tool can rapidly decode brain tumor DNA during surgery

More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapy

Cellectar to seek approval for radioactive iodine-based therapy in rare blood cancer

Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe